SALT LAKE CITY, Feb. 17, 2022 / — PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application … Continue reading PolarityTE (NASDAQ: PTE)Announces Allowance of Fourth U.S. Patent